Severe asthma paediatric - dupilumab or omalizumab - initial or recommencement authority application form (PB188)

Use this form to apply for initial PBS-subsidised treatment with dupilumab or omalizumab for patients 6 to under 12 years with uncontrolled severe asthma or uncontrolled severe allergic asthma.

You must download our forms to fill them in. We have help available if you use assistive technology or if you need a translator or interpreter. Find out how to use our forms.

You can upload this form in HPOS.

You can also use this form to apply to recommence PBS-subsidised treatment with dupilumab or omalizumab in a new treatment cycle following a mandatory 12-month break.

Please note: You don’t need to complete this form if you use the Online PBS Authorities system.

Download and complete the severe asthma paediatric - dupilumab or omalizumab - initial or recommencement authority application form.

Page last updated: 1 September 2025.
QC 35876